Araştırma Makalesi

Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients

Cilt: 15 Sayı: 4 31 Aralık 2024
PDF İndir
TR EN

Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients

Öz

Aim: Complete decongestive therapy (CDT) is the standard treatment of postmastectomy lymphedema. Our study aimed to determine the factors that impair compliance with the compression garment, one of the main phases of CDT, and to reduce the limiting effects of lymphedema by increasing the treatment compliance of lymphedema patients. Material and Methods: In this prospective study, demographic and clinical information of the patients were recorded. The stage of lymphedema (International Society of Lymphology (ISL)) and whether they had received lymphedema treatment before were questioned. The experience of pressure garment use was evaluated with a 5-point Likert-type scale questionnaire covering factors affecting patient compliance. Results: The mean age of 71 postmastectomy lymphedema patients was 56.3±8.6 years. 29 patients (40.8%) used their compression garments regularly every day, while 42 (59.1%) patients did not use them regularly. Regarding the mean score values, the top 3 reasons for limiting factors impairing compliance with the pressure garment were as follows: the patients had the most problems putting on and taking off the garment (3.94±1.30), had difficulty in housework in daily life (3.92±1.36), and had difficulty in participating in sports and hobby activities (3.84±1.41). Conclusion: Patients' specific characteristics, lifestyle, and history are important in the selection of compression garments. It is important to identify factors that impair compliance with the compression garment, to inform patients about lymphedema preventive measures, and to enable them to better adapt to daily life with the compression garment may improve self-treatment management and reduce the need for caregivers

Anahtar Kelimeler

Etik Beyan

Ankara Dr. Abdurrahman Yurtaslan Onkoloji Eğitim ve Araştırma Hastanesi Etik Kurulu 2021-06/1246 onay numarası ile Haziran 2021'de çalışmayı onaylamıştır. Hastalardan bilgilendirilmiş onam formları alınmıştır. Çalışma, 1975 Helsinki Bildirgesi'nden kaynaklanan araştırmalar için genel kabul görmüş etik ilkeler kullanılarak yürütülmüştür.

Kaynakça

  1. Shamoun, S. and M. Ahmad, Complete Decongestive Therapy Effect on Breast Cancer Related to Lymphedema: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Asian Pac J Cancer Prev, 2023. 24(7): p. 2225-2238.
  2. Torgbenu, E., T. Luckett, M.A. Buhagiar, and J.L. Phillips, Guidelines relevant to diagnosis, assessment, and management of lymphedema: a systematic review. Advances in Wound Care, 2023. 12(1): p. 15-27.
  3. McGlynn, K.A., J.L. Petrick, and H.B. El-Serag, Epidemiology of Hepatocellular Carcinoma. Hepatology, 2021. 73 Suppl 1(Suppl 1): p. 4-13.
  4. Hobday, A., Continuing Professional Development. Use of compression therapy in patients with lymphoedema. Nursing Standard, 2016. 30(27).
  5. Witte, M. and M. Bernas, Evolution of the 2020 International Society of Lymphology Consensus document parallels advances in Lymphology: An Historical Perspective. Lymphology, 2020. 53(1).
  6. Keeley, V., S. Crooks, J. Locke, D. Veigas, K. Riches, and R. Hilliam, A quality of life measure for limb lymphoedema (LYMQOL). Journal of Lymphoedema, 2010. 5(1): p. 26-37.
  7. Rockson, S.G., P. Karaca-Mandic, R. Skoracki, et al., Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, an Open-Label Controlled Study. Lymphat Res Biol, 2022. 20(2): p. 125-132.
  8. Monteiro, A.J., C. de Labra, M.E. Losa-Iglesias, et al., Depressive symptoms and their severity in a sample with lymphedema: a case-control investigation. Front Psychiatry, 2023. 14: p. 1202940.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri (Diğer)

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

31 Aralık 2024

Gönderilme Tarihi

28 Ağustos 2024

Kabul Tarihi

30 Ekim 2024

Yayımlandığı Sayı

Yıl 2024 Cilt: 15 Sayı: 4

Kaynak Göster

APA
Keskin Kavak, S., & Aktekin, L. (2024). Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients. Turkish Journal of Clinics and Laboratory, 15(4), 547-553. https://doi.org/10.18663/tjcl.1540060
AMA
1.Keskin Kavak S, Aktekin L. Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients. TJCL. 2024;15(4):547-553. doi:10.18663/tjcl.1540060
Chicago
Keskin Kavak, Songül, ve Lale Aktekin. 2024. “Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients”. Turkish Journal of Clinics and Laboratory 15 (4): 547-53. https://doi.org/10.18663/tjcl.1540060.
EndNote
Keskin Kavak S, Aktekin L (01 Aralık 2024) Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients. Turkish Journal of Clinics and Laboratory 15 4 547–553.
IEEE
[1]S. Keskin Kavak ve L. Aktekin, “Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients”, TJCL, c. 15, sy 4, ss. 547–553, Ara. 2024, doi: 10.18663/tjcl.1540060.
ISNAD
Keskin Kavak, Songül - Aktekin, Lale. “Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients”. Turkish Journal of Clinics and Laboratory 15/4 (01 Aralık 2024): 547-553. https://doi.org/10.18663/tjcl.1540060.
JAMA
1.Keskin Kavak S, Aktekin L. Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients. TJCL. 2024;15:547–553.
MLA
Keskin Kavak, Songül, ve Lale Aktekin. “Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients”. Turkish Journal of Clinics and Laboratory, c. 15, sy 4, Aralık 2024, ss. 547-53, doi:10.18663/tjcl.1540060.
Vancouver
1.Songül Keskin Kavak, Lale Aktekin. Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients. TJCL. 01 Aralık 2024;15(4):547-53. doi:10.18663/tjcl.1540060


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.